Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 101.43B | 101.43B | 99.94B | 93.85B | 80.79B | 86.96B |
Gross Profit | 15.68B | 15.68B | 15.65B | 15.27B | 14.36B | 10.86B |
EBITDA | 6.63B | 10.47B | 9.17B | 8.24B | 8.46B | 5.22B |
Net Income | 2.16B | 2.16B | 1.11B | -1.68B | 1.32B | -125.00M |
Balance Sheet | ||||||
Total Assets | 109.95B | 109.95B | 111.54B | 100.11B | 96.92B | 93.89B |
Cash, Cash Equivalents and Short-Term Investments | 1.76B | 1.76B | 3.11B | 3.71B | 5.06B | 4.25B |
Total Debt | 41.15B | 41.15B | 39.78B | 36.70B | 36.15B | 37.44B |
Total Liabilities | 71.11B | 71.11B | 70.94B | 67.91B | 65.00B | 65.50B |
Stockholders Equity | 37.93B | 37.93B | 39.72B | 31.43B | 31.06B | 27.56B |
Cash Flow | ||||||
Free Cash Flow | 0.00 | -3.45B | -3.14B | -1.26B | 1.72B | -3.65B |
Operating Cash Flow | 0.00 | 1.73B | 2.97B | 4.88B | 5.08B | 318.00M |
Investing Cash Flow | 0.00 | -3.13B | -5.05B | -5.44B | -2.37B | -2.88B |
Financing Cash Flow | 0.00 | -138.00M | 1.25B | -940.00M | -2.47B | 2.22B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
80 Outperform | ¥11.74B | 6.81 | 3.66% | 0.93% | -7.85% | ||
78 Outperform | ¥10.35B | 6.02 | 3.04% | -7.85% | -34.41% | ||
78 Outperform | ¥11.75B | 4.53 | 2.35% | -4.83% | 5.31% | ||
74 Outperform | ¥12.82B | 5.11 | 3.66% | 0.85% | 94.79% | ||
68 Neutral | ¥25.78B | 7.47 | 3.25% | 20.25% | ― | ||
61 Neutral | $17.99B | 12.87 | -3.56% | 2.97% | 1.27% | -14.28% | |
56 Neutral | ¥10.10B | ― | 2.25% | -3.20% | -454.63% |